Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study Effects of Ultra-slow Continuous Intravenous Infusion of Unfractionated Heparin on Progressive Cerebral Infarction - a Clinical Study

NCT01378000 is registered in ClinicalTrials.gov with Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine as lead sponsor.

NCT NCT01378000
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01378000 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study Effects of Ultra-slow Continuous Intravenous Infusion of Unfractionated Heparin on Progressive Cerebral Infarction - a Clinical Study
Lead sponsor
Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine
Phase
Observational
Overall status
Completed
Start date
October 31, 2009
Completion date
August 31, 2010
Enrollment
480 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute cerebral ischemia, heparin causing adverse effects in therapeutic use, heparin-induced thrombosis